ADMA
ADMA Biologics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website admabiologics.com
- Employees(FY) 617
- ISIN US0008991046
Performance
+32.9%
1W
+49.51%
1M
+74.43%
3M
+141.73%
6M
+103.76%
YTD
+124.09%
1Y
Profile
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Investment Analysis Report: ADMA
Overview
ADMA is a biotechnology company operating in the Health Technology sector with a market capitalization of $1.19 billion. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expe...
Technical Analysis of ADMA 2024-05-10
Overview:
In analyzing the technical indicators for ADMA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-16 06:13
- 2024-05-15 08:05
- 2024-05-13 09:40
- 2024-05-12 21:40
- 2024-05-11 09:25
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-05-10 14:26
- 2024-05-10 13:25
- 2024-05-10 10:57
- 2024-05-10 04:06
- 2024-05-10 02:26
- 2024-05-09 18:20
- 2024-05-09 17:17
Adma Biologics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-09 16:05
- 2024-05-09 06:20
- 2024-05-09 04:05
- 2024-05-02 17:45
- 2024-05-02 07:00
- 2024-05-02 05:45
- 2024-05-01 19:00
- 2024-04-30 09:30
- 2024-04-29 21:30
- 2024-04-29 11:26
- 2024-04-29 08:16
- 2024-04-28 23:26
- 2024-04-25 17:45
- 2024-04-25 05:45
- 2024-04-24 08:50
- 2024-04-23 20:50
- 2024-04-19 17:45
- 2024-04-19 05:45
Page 1 of 10
previousnext